The Omicron variant is spreading rapidly in the United States and could trigger a huge wave of COVID infections as early as January, federal health officials said Tuesday. In just one week there was a sevenfold spike in the highly contagious variant’s presence across the nation, according to the U.S. Centers for Disease Control and…  read on >  read on >

When it comes to fending off new viruses, baby has Mom and Dad beat. An infant’s immune system is better than an adult’s at combating new viruses, researchers say. Compared to adults, babies get a lot of viral respiratory infections, but babies are dealing with these viruses for the first time, study author Donna Farber…  read on >  read on >

Compared to previous coronavirus variants, Omicron appears to cause less severe illness, but is more resistant to the Pfizer vaccine, researchers at South Africa’s largest health insurer report. The team at Discovery Health analyzed 211,000 positive coronavirus cases during the country’s fourth wave, including 78,000 attributed to Omicron. It’s the first major private study since…  read on >  read on >

Pfizer Inc. announced Tuesday that a final analysis shows its experimental antiviral pill Paxlovid sharply reduced hospitalizations and deaths among people at high risk for severe illness. The latest results, which reinforce an earlier analysis released in November, show that Pfizer’s drug cut hospitalizations and deaths by nearly 90 percent when taken within three to…  read on >  read on >

A new study confirms yet another consequence of the pandemic for children and teenagers: Eating disorders, and hospitalizations for them, rose sharply in 2020. The study of six hospitals across Canada found new diagnoses of anorexia nearly doubled during the first wave of the COVID-19 pandemic. And the rate of hospitalization among those patients was…  read on >  read on >

The COVID-19 death toll in the United States reached 800,000 on Monday, and one expert believes it will likely hit 1 million at some point in 2022. The 800,156 confirmed deaths in the nearly two years since the first known U.S. victims of the coronavirus were confirmed in February 2020 is more than any other…  read on >  read on >

The ability of two-dose COVID-19 vaccines to protect against symptomatic infection by the Omicron variant falls significantly short, but a booster shot provides considerable protection, according to the first real-world study of how effective vaccines are against the rapidly spreading new form of the coronavirus. Four months after their second dose of the Pfizer-BioNTech vaccine,…  read on >  read on >